Filing Details

Accession Number:
0000899243-20-021585
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-05 21:55:06
Reporting Period:
2020-08-03
Accepted Time:
2020-08-05 21:55:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1754068 Allovir Inc. ALVR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1743662 B Jeroen Beek Van C/O Allovir, Inc.
139 Main Street, Suite 500
Cambridge MA 02142
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-03 6,710 $0.00 521,640 No 4 C Direct
Common Stock Acquisiton 2020-08-03 3,000 $17.00 524,640 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2020-08-03 10,000 $0.00 6,710 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date.